Allergan is bulking up its drug pipeline, announcing two new acquisitions. Jim Cramer spoke with the company’s CEO to get his take on its prospects.
source CNBC
Allergan CEO Brent Saunders: Our Stock Is Undervalued | Mad Money | CNBC
Allergan is bulking up its drug pipeline, announcing two new acquisitions. Jim Cramer spoke with the company’s CEO to get his take on its prospects.
source CNBC
previous post